Pharmaceutical industry news

Clinical management of vestibular schwannoma – what’s the evidence?

Correction: Distinguishing reactive scoliosis: clinical presentation, pathophysiology and a proposed clinical framework

Characteristics of patients with epithelioid hemangioendothelioma (EHE): a retrospective analysis of the Charité- Universitätsmedizin Berlin

EDI-OCT detection of sub-Tenon’s fluid in posterior scleritis in myopic eyes: a retrospective case series

Pharmacogenomic screening strategy and indicative screening efficiency for antithyroid drug-induced agranulocytosis in the Southern Han Chinese

Pragmatic Clinical Trial of Fostamatinib as Second‐Line Therapy in Adult Patients With Immune Thrombocytopenia and Insufficient Response to Prior Therapy: The Fostamatinib FORTE Trial

Complete lesion resection and early surgical intervention are favorable factors for long‐term seizure freedom in drug‐resistant epileptic spasms

Enterprise value to revenue forward of Annji Pharmaceutical Co., Ltd. – TPEX:7754

Sleep apnea pill maker Apnimed files for US IPO as biotech market revives

ETFs Investing in Hunan Warrant Pharmaceutical Co., Ltd. Class A Stocks

Landmark Clinical Trial Results in First FDA-Approved Treatment for Rare Form of Obesity Caused by Brain Injury | Newswise

Two Preventable Semaglutide Dosing Errors May Have Driven a Surge in Poison Control Calls

Can M&A momentum carry biotech through year-end?

Is This Biotech Stock a Buy Near Its 52-Week High?

US FDA Proposes One Registration For Distributed Drug Manufacturing Networks

Apnimed files for IPO as FDA reviews its sleep apnea drug

Is This Biotech Stock a Buy Near Its 52-Week High?

West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors

Roche Ends Both Huntington’s Disease Drug Programs After Biomarkers Beat Patients

Partnership for Safe Medicines urges FDA advisory committee to reject compounding of unapproved peptides

LB Pharmaceuticals Grants Inducement Equity Award to New Senior Vice President of Clinical Operations

Biotech Stocks Are Projected to Extend Rally Amid Innovation and M&A

Is There A Semaglutide Shortage? Ozempic and Wegovy Availability Updates

FDA to Rule July 17 on Gedatolisib, First Targeted Therapy for PIK3CA Wild-Type Breast Cancer

FDA’s rule seeks to modernize drug manufacturing registration

Why This Pharmaceutical Stock Jumped Close to 100% This Week

FDA Proposes Rule To Simplify Drug Manufacturing Registration

FDA proposes drug registration changes to boost supply chain transparency

US FDA proposes rule to simplify registration for some drug manufacturers

Why This Pharmaceutical Stock Jumped Close to 100% This Week

West Pharmaceutical Services (WST) Sells SmartDose Rights To AbbVie To Refocus Its Business

Korea’s HLB fails to win FDA approval on liver cancer drug for 3rd time; stocks hit 9-month low

Keeping pace with generative AI in pharmaceutical and healthcare organisations

Abbott Labs Vs. Danaher: Abbott’s Everyday Products Beat Danaher’s Slumping Biotech Equipment

Chinese Biotech Taking Early-Phase Precision Medicine Trials to Australia Amid US Restrictions

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Canc

FDA's CRL Disclosure Freeze and DTC Ad Crackdown Likely Headed for Court, Sue Sutter and Derrick Gingery Warn

Sanofi Wins FDA Approval for Wearable Injector Form of Blood Cancer Drug

FDA clears Phase II trial for rare skin disorder drug

Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It.

FDA rejects Hengrui-Elevar liver cancer drug combo for third time

NMPA in China approves Heng Yi cyclosporine drop

Recursion Pharmaceuticals Stock (RXRX) Opinions on Biotech AI Prospects

FDA Approves Subcutaneous Sarclisa Escena | PharmExec

OKYO's urcosimod gets FDA nod, moves to global phase 3 trial for NCP

RegenxBio doses first patient in phase 2b/3 trial for DR

Takeda Pharmaceutical (TSE:4502) Taps Pharma.AI For Drug Discovery, Is The Stock Still Cheap?

Ministers launch crackdown on vapes targeting kids

Ministers have launched a crackdown on vapes marketed at kids with a shift to plain white packaging.

Bhiwandi Food Safety Drive: BNCMC, FDA To Crack Down On Illegal Food Businesses After Mass Food Poisoning

FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy

Forte Biosciences' Vitiligo Triumph: A High-Stakes Bet on Broad Autoimmune Potential

FDA Approves Perioperative Pembro Plus Enfortumab Vedotin for Muscle-Invasive Bladder Cancer

Keeping pace with generative AI in pharmaceutical and healthcare organisations

Weekly Buzz: JNJ, VERA Get FDA Nod; VRTX Snaps Up CRNX; MSLE Aces DMD Trial; IONS Misses Key Goal

Biotech Stocks To Keep An Eye On - July 10th

Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout

Pharmaceutical marketplaces: How online platforms are changing drug purchasing

HLB, Hengrui receive third US FDA rejection on liver cancer combo

'We're paranoid.' As China biotech competition heats up, American drugmakers get more secretive

GSK, Hansoh ADC extends survival in lung cancer study